Hans Lennernäs
Impact in
- Pharmaceutical Science top 0.01%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Drug Solubulity and Delivery Systems 84
- Advanced Drug Delivery Systems 37
- Oncology 140
- Drug Transport and Resistance Mechanisms 122
- Co-authors
- Gordon L. AmidonVinod P. ShahJohn R. CrisonUrban FagerholmLars KnutsonDavid DahlgrenBertil AbrahamssonGunnar Fager
- Journals
- European Journal of Pharmaceutical Sciences (29 papers)Molecular Pharmaceutics (29 papers)Pharmaceutical Research (27 papers)Drug Metabolism and Disposition (15 papers)Journal of Pharmacy and Pharmacology (14 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Hans Lennernäs
266 papers receiving 16.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Pharmaceutical Science 7.6k
- Pharmacology 2.2k
- Oncology 5.4k
- Analytical Chemistry 1.6k
- Gastroenterology 781
Countries citing papers authored by Hans Lennernäs
This map shows the geographic impact of Hans Lennernäs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Lennernäs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Lennernäs more than expected).
Fields of papers citing papers by Hans Lennernäs
This network shows the impact of papers produced by Hans Lennernäs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Lennernäs. The network helps show where Hans Lennernäs may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hans Lennernäs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 20 | |
| 7 | 2022 | 10 | |
| 8 | 2020 | 22 | |
| 9 | 2020 | 1 | |
| 10 | 2016 | 42 | |
| 11 | Intercurrent Illness Dose Regimen in Adrenal Insufficiency with a Dual Release Hydrocortisone Formulation Derived from Population Pharmacokinetic Modelling | 2012 | 2 |
| 12 | 2011 | 33 | |
| 13 | 2010 | 3 | |
| 14 | 2009 | 135 | |
| 15 | 2008 | 23 | |
| 16 | Improved glucocorticoid replacement therapy by a novel oral hydrocortisone modified-release tablet | 2007 | 1 |
| 17 | 2001 | 54 | |
| 18 | 2000 | 16 | |
| 19 | A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability Hit paper breakdown → | 1995 | 4159 |
| 20 | 1994 | 33 |
About Hans Lennernäs
Hans Lennernäs is a scholar working on Pharmaceutical Science, Oncology, Pharmacology, Gastroenterology and Pediatrics, Perinatology and Child Health, having authored 269 papers that have together received 17.4k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (122 papers), Drug Solubulity and Delivery Systems (84 papers), Advanced Drug Delivery Systems (37 papers), Pharmacological Effects and Toxicity Studies (35 papers), Pharmacogenetics and Drug Metabolism (28 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers), Analytical Chemistry and Chromatography (19 papers) and Pharmaceutical studies and practices (16 papers). The work is most often cited by research in Pharmaceutical Science (7.6k citations), Pharmacology (2.2k citations), Oncology (5.4k citations), Analytical Chemistry (1.6k citations) and Gastroenterology (781 citations). Hans Lennernäs has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Gordon L. Amidon, Vinod P. Shah, John R. Crison, Urban Fagerholm, Lars Knutson, David Dahlgren, Bertil Abrahamsson, Gunnar Fager, Erik Sjögren and Anders Lindahl. Their work appears in journals such as European Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, Pharmaceutical Research, Drug Metabolism and Disposition and Journal of Pharmacy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.